Logo image of RHT.CA

RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) Stock Fundamental Analysis

TSX-V:RHT - TSX Venture Exchange - CA75955T1030 - Common Stock - Currency: CAD

0.215  0 (0%)

Fundamental Rating

4

RHT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 8 industry peers in the Health Care Technology industry. While RHT seems to be doing ok healthwise, there are quite some concerns on its profitability. RHT is growing strongly while it is still valued neutral. This is a good combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RHT has reported negative net income.
In the past year RHT has reported a negative cash flow from operations.
RHT had negative earnings in each of the past 5 years.
In the past 5 years RHT always reported negative operating cash flow.
RHT.CA Yearly Net Income VS EBIT VS OCF VS FCFRHT.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -2M -4M -6M -8M -10M

1.2 Ratios

With a decent Return On Assets value of -2.05%, RHT is doing good in the industry, outperforming 75.00% of the companies in the same industry.
RHT's Return On Equity of -3.41% is amongst the best of the industry. RHT outperforms 87.50% of its industry peers.
Industry RankSector Rank
ROA -2.05%
ROE -3.41%
ROIC N/A
ROA(3y)-277.14%
ROA(5y)-257.7%
ROE(3y)-803.99%
ROE(5y)-598.14%
ROIC(3y)N/A
ROIC(5y)N/A
RHT.CA Yearly ROA, ROE, ROICRHT.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -2K -4K -6K -8K -10K

1.3 Margins

RHT's Gross Margin of 60.61% is in line compared to the rest of the industry. RHT outperforms 50.00% of its industry peers.
In the last couple of years the Gross Margin of RHT has grown nicely.
The Profit Margin and Operating Margin are not available for RHT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y143.2%
GM growth 5Y26.85%
RHT.CA Yearly Profit, Operating, Gross MarginsRHT.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 -2K -4K -6K

More info and screens

4

2. Health

2.1 Basic Checks

RHT does not have a ROIC to compare to the WACC, probably because it is not profitable.
RHT has more shares outstanding than it did 1 year ago.
RHT has a better debt/assets ratio than last year.
RHT.CA Yearly Shares OutstandingRHT.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
RHT.CA Yearly Total Debt VS Total AssetsRHT.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of 0.13, we must say that RHT is in the distress zone and has some risk of bankruptcy.
RHT has a Altman-Z score of 0.13. This is in the better half of the industry: RHT outperforms 62.50% of its industry peers.
RHT has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.01, RHT belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.13
ROIC/WACCN/A
WACC9.53%
RHT.CA Yearly LT Debt VS Equity VS FCFRHT.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 5M -5M 10M -10M

2.3 Liquidity

A Current Ratio of 1.86 indicates that RHT should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.86, RHT belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
RHT has a Quick Ratio of 1.79. This is a normal value and indicates that RHT is financially healthy and should not expect problems in meeting its short term obligations.
RHT has a better Quick ratio (1.79) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.79
RHT.CA Yearly Current Assets VS Current LiabilitesRHT.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 94.41% over the past year.
RHT shows a strong growth in Revenue. In the last year, the Revenue has grown by 119.37%.
The Revenue has been growing by 115.82% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)94.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%186.44%
Revenue 1Y (TTM)119.37%
Revenue growth 3Y260.91%
Revenue growth 5Y115.82%
Sales Q2Q%88.51%

3.2 Future

The Earnings Per Share is expected to grow by 68.33% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 126.89% on average over the next years. This is a very strong growth
EPS Next Y123.08%
EPS Next 2Y64.08%
EPS Next 3Y68.33%
EPS Next 5YN/A
Revenue Next Year106.52%
Revenue Next 2Y102.94%
Revenue Next 3Y126.89%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
RHT.CA Yearly Revenue VS EstimatesRHT.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
RHT.CA Yearly EPS VS EstimatesRHT.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2023 2024 2025 0 0.05 -0.05 0.1

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

RHT is valuated cheaply with a Price/Forward Earnings ratio of 6.96.
Based on the Price/Forward Earnings ratio, RHT is valued cheaper than 100.00% of the companies in the same industry.
RHT is valuated cheaply when we compare the Price/Forward Earnings ratio to 21.94, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 6.96
RHT.CA Price Earnings VS Forward Price EarningsRHT.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RHT.CA Per share dataRHT.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04 0.06

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as RHT's earnings are expected to grow with 68.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y64.08%
EPS Next 3Y68.33%

More info and screens

0

5. Dividend

5.1 Amount

RHT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RELIQ HEALTH TECHNOLOGIES IN

TSX-V:RHT (1/16/2024, 7:00:00 PM)

0.215

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap41.56M
Analysts84.44
Price Target1.79 (732.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.96
P/S 2.84
P/FCF N/A
P/OCF N/A
P/B 3.1
P/tB 3.1
EV/EBITDA N/A
EPS(TTM)0
EYN/A
EPS(NY)0.03
Fwd EY14.37%
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.08
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.05%
ROE -3.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.61%
FCFM N/A
ROA(3y)-277.14%
ROA(5y)-257.7%
ROE(3y)-803.99%
ROE(5y)-598.14%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y143.2%
GM growth 5Y26.85%
F-Score2
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.79
Altman-Z 0.13
F-Score2
WACC9.53%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)94.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%186.44%
EPS Next Y123.08%
EPS Next 2Y64.08%
EPS Next 3Y68.33%
EPS Next 5YN/A
Revenue 1Y (TTM)119.37%
Revenue growth 3Y260.91%
Revenue growth 5Y115.82%
Sales Q2Q%88.51%
Revenue Next Year106.52%
Revenue Next 2Y102.94%
Revenue Next 3Y126.89%
Revenue Next 5YN/A
EBIT growth 1Y84.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year105.4%
EBIT Next 3Y80.52%
EBIT Next 5YN/A
FCF growth 1Y-8.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.01%
OCF growth 3YN/A
OCF growth 5YN/A